ENDEFR
Home › United States › Sanofi-Synthelabo LLC

Sanofi-Synthelabo LLC

Limited Liability Company · Wilmington, United States · LEI 549300MJCQ68JEVQD278
LEI lapsed

Summary

Sanofi-Synthelabo LLC is registered in the United States. Its legal form is Limited Liability Company. No parent is reported to GLEIF. GLEIF gives this reason: the parent information is not public, because of legal constraints, possible detriment, or because consent was not obtained. It has 1 direct subsidiary in GLEIF data; 1 of them has a lapsed LEI. The LEI was first issued on 2 Apr 2013 and the record was last updated on 16 Aug 2023. It has lapsed: renewal was due by 25 Jan 2019. AssetCensus found 1 data-quality note for this entity (see below).

Written from GLEIF data using fixed, reviewed sentence templates.

Data-quality notes (AssetCensus analysis)

  • The LEI has lapsed: it was due for renewal by 25 Jan 2019 and was not renewed, so GLEIF's data for this entity has not been re-verified since. A lapsed LEI does not mean the company has ceased to exist.

Company details

Legal formLimited Liability Company
Register · Register website
Registration number2184320
Registration authorityDivision of Corporations, Department of State
JurisdictionUnited States (US-DE)
Registered addressC/O Corporation Service Company, 251 Little Falls Drive, 19808 Wilmington, United States
Headquarters address55 Corporate Drive, 08807 Bridgewater, United States
Categorycompany or other legal entity
Statusactive
Founded (per GLEIF)13 Jan 1989
LEI549300MJCQ68JEVQD278
LEI statuslapsed
LEI first issued2 Apr 2013
LEI record last updated16 Aug 2023
Next LEI renewal25 Jan 2019
Corroboration of the LEI recordfully corroborated

Group membership

Sanofi-Synthelabo LLC this entity
Sanofi-Aventis Canada Inc. Canada lapsed

Parent not reported to GLEIF

  • Direct parent: the parent information is not public, because of legal constraints, possible detriment, or because consent was not obtained.
  • Ultimate parent: the parent information is not public, because of legal constraints, possible detriment, or because consent was not obtained.

Direct subsidiaries (1)